|
1
|
Sanguinetti A, Polistena A, Lucchini R,
Monacelli M, Avenia S, Conti C, Barillaro I, Rondelli F,
Bugiantella W and Avenia N: Breast cancer in older women: What
factors affect the treatment? Int J Surg. 12(Suppl 2): S177–S180.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay JSI, Ervik M, Dikshit R, Eser S,
Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012
v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.
11. (Lyon, France). International Agency for Research on Cancer.
2013.http://globocan.iarc.frAccessed. December
12–2013
|
|
3
|
Zeng H, Zheng R, Zhang S, Zou X and Chen
W: Female breast cancer statistics of 2010 in China: Estimates
based on data from 145 population-based cancer registries. J Thorac
Dis. 6:466–470. 2014.PubMed/NCBI
|
|
4
|
Lin G, Zhu W, Yang L, Wu J, Lin B, Xu Y,
Cheng Z, Xia C, Gong Q, Song B and Ai H: Delivery of siRNA by
MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR
human breast cancer cells. Biomaterials. 35:9495–9507. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amirzada MI, Ma X, Gong X, Chen Y, Bashir
S and Jin J: Recombinant human interleukin 24 reverses Adriamycin
resistance in a human breast cancer cell line. Pharmacol Rep.
66:915–919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bright-Gbebry M, Makambi KH, Rohan JP,
Llanos AA, Rosenberg L, Palmer JR and Adams-Campbell LL: Use of
multivitamins, folic acid and herbal supplements among breast
cancer survivors: the black women's health study. BMC Complement
Altern Med. 11:302011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spazzapan S, Crivellari D, Bedard P,
Lombardi D, Miolo G, Scalone S and Veronesi A: Therapeutic
management of breast cancer in the elderly. Expert Opin
Pharmacother. 12:945–960. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li WY, Chan SW, Guo DJ, Chung MK, Leung TY
and Yu PH: Water extract of Rheum officinale Baill. induces
apoptosis in human lung adenocarcinoma A549 and human breast cancer
MCF-7 cell lines. J Ethnopharmacol. 124:251–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang C, Wu X, Chen M, Duan W, Sun L, Yan M
and Zhang L: Emodin induces apoptosis through caspase 3-dependent
pathway in HK-2 cells. Toxicology. 231:120–128. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li WY, Ng YF, Zhang H, Guo ZD, Guo DJ,
Kwan YW, Leung GP, Lee SM, Yu PH and Chan SW: Emodin elicits
cytotoxicity in human lung adenocarcinoma A549 cells through
inducing apoptosis. Inflammopharmacology. 22:127–134. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li WY, Chan RY, Yu PH and Chan SW: Emodin
induces cytotoxic effect in human breast carcinoma MCF-7 cell
through modulating the expression of apoptosis-related genes. Pharm
Biol. 51:1175–1181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sui JQ, Xie KP, Zou W and Xie MJ: Emodin
inhibits breast cancer cell proliferation through the
ERα-MAPK/Akt-cyclin D1/Bcl-2 signaling pathway. Asian Pac J Cancer
Prev. 15:6247–6251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pooja T and Karunagaran D: Emodin
suppresses Wnt signaling in human colorectal cancer cells SW480 and
SW620. Eur J Pharmacol. 742:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei WT, Lin SZ, Liu DL and Wang ZH: The
distinct mechanisms of the antitumor activity of emodin in
different types of cancer (Review). Oncol Rep. 30:2555–2562.
2013.PubMed/NCBI
|
|
15
|
Xu JD, Liu S, Wang W, Li LS, Li XF, Li Y,
Guo H, Ji T, Feng XY, Hou XL, et al: Emodin induces chloride
secretion in rat distal colon through activation of mast cells and
enteric neurons. Br J Pharmacol. 165:197–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue H, Chen Y, Cai X, Zhao L, He A, Guo K
and Zheng X: The combined effect of survivin-targeted shRNA and
emodin on the proliferation and invasion of ovarian cancer cells.
Anticancer Drugs. 24:937–944. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yaoxian W, Hui Y, Yunyan Z, Yanqin L, Xin
G and Xiaoke W: Emodin induces apoptosis of human cervical cancer
hela cells via intrinsic mitochondrial and extrinsic death receptor
pathway. Cancer Cell Int. 13:712013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Way TD, Huang JT, Chou CH, Huang CH, Yang
MH and Ho CT: Emodin represses TWIST1-induced
epithelial-mesenchymal transitions in head and neck squamous cell
carcinoma cells by inhibiting the β-catenin and Akt pathways. Eur J
Cancer. 50:366–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin SZ, Wei WT, Chen H, Chen KJ, Tong HF,
Wang ZH, Ni ZL, Liu HB, Guo HC and Liu DL: Antitumor activity of
emodin against pancreatic cancer depends on its dual role:
Promotion of apoptosis and suppression of angiogenesis. PLoS One.
7:e421462012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muppidi J, Porter M and Siegel RM:
Measurement of apoptosis and other forms of cell death. Curr Protoc
Immunol. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelly PN and Strasser A: The role of Bcl-2
and its pro-survival relatives in tumourigenesis and cancer
therapy. Cell Death Differ. 18:1414–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strasser A, Cory S and Adams JM:
Deciphering the rules of programmed cell death to improve therapy
of cancer and other diseases. EMBO J. 30:3667–3683. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heath RM, Jayne DG, O'Leary R, Morrison EE
and Guillou PJ: Tumour-induced apoptosis in human mesothelial
cells: A mechanism of peritoneal invasion by Fas Ligand/Fas
interaction. Br J Cancer. 90:1437–1442. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Geng QQ, Dong DF, Chen NZ, Wu YY, Li EX,
Wang J and Wang SM: Induction of p53 expression and apoptosis by a
recombinant dual-target MDM2/MDMX inhibitory protein in wild-type
p53 breast cancer cells. Int J Oncol. 43:1935–1942. 2013.PubMed/NCBI
|
|
26
|
Harris SL and Levine AJ: The p53 pathway:
positive and negative feedback loops. Oncogene. 24:2899–2908. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leard LE and Broaddus VC: Mesothelial cell
proliferation and apoptosis. Respirology. 9:292–299. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fang CC, Yen CJ, Tsai TJ, Chen RH, Lee PH
and Tomino Y: Antibiotics induce apoptosis of human peritoneal
mesothelial cells. Nephrology (Carlton). 8:142–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Korsmeyer SJ, Shutter JR, Veis DJ, Merry
DE and Oltvai ZN: Bcl-2/Bax: a rheostat that regulates an
anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332.
1993.PubMed/NCBI
|
|
30
|
Lindsay J, Esposti MD and Gilmore AP:
Bcl-2 proteins and mitochondria-specificity in membrane targeting
for death. Biochim Biophys Acta. 1813:532–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma L and Li W: Emodin inhibits LOVO
colorectal cancer cell proliferation via the regulation of the
Bcl-2/Bax ratio and cytochrome c. Exp Ther Med. 8:1225–1228.
2014.PubMed/NCBI
|
|
32
|
Wang X: The expanding role of mitochondria
in apoptosis. Genes Dev. 15:2922–2933. 2001.PubMed/NCBI
|
|
33
|
Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao
Y, Li ML, Wu KJ and Liu YB: Curcumin induces apoptosis in
gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int.
13:642013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu J, Wu N, Ma LN, Zhong JT, Liu G, Zheng
LH and Lin XK: p38 MAPK signaling mediates mitochondrial apoptosis
in cancer cells induced by oleanolic acid. Asian Pac J Cancer Prev.
15:4519–4525. 2014. View Article : Google Scholar : PubMed/NCBI
|
